$400 Million

Theravance Biopharma

Sole Placement Agent, February 2020

Fixed Rate Term Notes

Theravance Biopharma, Inc. is a diversified biopharmaceutical company primarily focused on the discovery, development, and commercialization of organ-selective medicines. The Company’s focus areas for research are inflammation and immunology.

More Like This

Mar 2020

Recapitalization by Main Street Capital Corporation

Exclusive Financial Advisor

View Details
Mar 2020
$150 Million

At-the-market Offering

View Details
Mar 2020

Sale to NORD Holding Unternehmensbeteiligungsgesellschaft mbH

Financial Advisor

View Details